Telix Pharmaceuticals Limited (TLX) Reports FY results; offers guidance

Go back to Telix Pharmaceuticals Limited (TLX) Reports FY results; offers guidance
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.09 --0 (-0%)
Previous Close $10.09    52 Week High $2.18 
Open $10.09    52 Week Low $0.30 
Day High $10.09    P/E N/A 
Day Low $10.09    EPS $-3.32 
Volume 10